Lincoln Pharmaceuticals Ltd

BSE: 531633

109

total announcements

LINCOLN.BO · 15 min delayed

Key Stats · Yahoo Finance · as of 09 Nov 2026

Market Cap

₹1,030 Cr

P/E (TTM)

10.6

EPS (TTM)

₹48.38

52W Low

₹439.95

52W High

₹770.00

Dividend Yield

0.35%

Beta

0.52

Price / Book

1.3

Return on Equity

12.69%

Debt / Equity

0.4

Revenue (TTM)

₹722 Cr

Gross Margin

50.74%

Operating Margin

10.35%

Announcements Discussion

BSECompany UpdateResults30 Oct 2026

Lincoln Pharmaceuticals Ltd

Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, we enclosed herewith the copies of newspaper intimation with respect to un-audited financial results for the quarter and half year ended on September 30, 2026.

Lincoln Pharmaceuticals Ltd has announced the publication of its un-audited financial results for the quarter and half year ended September 30, 2026, as required by Regulation 47 of SEBI (LODR) Regulations, 2015.

Read more →📎 1 attachment

BSEResultResults29 Oct 2026

Lincoln Pharmaceuticals Ltd

Un-Audited Financial Results For the Quarter and Half year Ended on September 30 ,2026.

Lincoln Pharmaceuticals Ltd has announced its un-audited financial results for the quarter and half year ended on September 30, 2026, with a net profit of ₹2,042.61 lakhs and ₹5,666.06 lakhs respectively.

Read more →📎 1 attachment

BSEBoard MeetingResults29 Oct 2026

Lincoln Pharmaceuticals Ltd

Un-Audited Financial Results For the Quarter and Half Year ended on September 30, 2026.

Lincoln Pharmaceuticals Ltd has announced its un-audited financial results for the quarter and half year ended on September 30, 2026, with a net profit of ₹2,042.61 lakhs and ₹5,666.06 lakhs respectively.

Read more →📎 1 attachment

BSEBoard MeetingResults22 Oct 2026

Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve Standalone and Consolidated Unaudited Financial Results of the Company for the Quarter and Half year ended 30.09.2026.

Lincoln Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 29/10/2026 to consider and approve Standalone and Consolidated Unaudited Financial Results for the Quarter and Half year ended 30.09.2026.

Read more →📎 1 attachment

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the BSE about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the exchange about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed BSE about the cessation of Sr. General Manager.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the BSE about the cessation of Sr. General Manager.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the BSE about the cessation of Sr. General Manager.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the exchange about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the exchange about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the BSE about the cessation of Sr. General Manager.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the exchange about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed BSE about the cessation of Sr. General Manager.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the BSE about the cessation of Sr. General Manager.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the BSE about the cessation of Sr. General Manager.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the exchange about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed BSE about the cessation of Sr. General Manager. The details are not provided.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the exchange about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed BSE about the cessation of Sr. General Manager.

Page 1 of 6Next →